Institut Curie

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Institut Curie
Oct 22, 2024, 03:40 | Insight
Etienne Brain: Inspiring works of the 2023/2024 Treviso delegates
Etienne Brain, Medical Oncologist at Institut Curie/Saint-Cloud, shared a post on X: “Last day of…
Oct 17, 2024, 11:40 | Blog
Isabelle Villadary: Hackathon dedicated to childhood cancer
Isabelle Villadary shared a post by Imagine for Margo - Children without Cancer on LinkedIn,…
Jul 7, 2024, 06:54 | Insight
Olivier Saulnier: Cellular origins of medulloblastoma
Olivier Saulnier, Junior Group Leader at Institut Curie, made the following post on X: "Excited…
Jun 28, 2024, 05:37 | Blog
Istvan Petak: Pleasure to give a talk at the Drug Development Course 2024
Istvan Petak shared on LinkedIn: “Hello, amazing Switzerland, beautiful Bellinzona. It was a pleasure to…
May 24, 2024, 14:50 | Insight
A new paper on VC-resist glioblastoma cell state out in Nature Communications
A groundbreaking new open-access paper was published in the prestigious journal, Nature Communications, titled "VC-resist…
May 24, 2024, 13:07 | Blog
France needs to accelerate its fight against cancer! - European Cancer Organisation
European Cancer Organisation shared a post on LinkedIn: “France needs to accelerate its fight against…
Apr 11, 2024, 17:17 | Insight
Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management
Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices…
Mar 14, 2024, 19:28 | Drugs
François-Clément Bidard: A prospective study to document the efficacy of the combo Fulvestrant+Everolimus
Erika Hamilton, Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute, shared…
Jul 16, 2023, 06:48 | Stories
Therapy Resistance and Metabolic reprogramming in ER+ breast cancer: what a combo - Andrea Morandi
📣 It's OUT! Therapy Resistance and Metabolic reprogramming in ER+ breast cancer: what a combo!…
All: 9 Posts: 1 - 100
Special Coverage